Centerbridge Partners - Q3 2021 holdings

$856 Million is the total value of Centerbridge Partners's 108 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 17.5% .

 Value Shares↓ Weighting
GOCO  GOHEALTH INC$204,635,000
-55.1%
40,682,9610.0%23.91%
-42.7%
RADI  RADIUS GLOBAL INFRASTRCTRE I$178,405,000
+12.6%
10,925,0000.0%20.85%
+43.9%
THC BuyTENET HEALTHCARE CORP$147,692,000
+2.8%
2,222,931
+3.6%
17.26%
+31.3%
GNK SellGENCO SHIPPING & TRADING LTD$91,885,000
-17.9%
4,564,583
-23.0%
10.74%
+4.9%
IWM NewISHARES TRput$78,750,000360,000
+100.0%
9.20%
FUN NewCEDAR FAIR L Pdepositry unit$31,939,000688,633
+100.0%
3.73%
GTX  GARRETT MOTION INC$24,984,000
-7.6%
3,390,0000.0%2.92%
+18.0%
CYH SellCOMMUNITY HEALTH SYS INC NEW$24,977,000
-31.2%
2,134,800
-9.3%
2.92%
-12.1%
VTIQ  VECTOIQ ACQUISITION CORP II$18,935,000
-2.9%
1,950,0000.0%2.21%
+24.1%
GDS BuyGDS HLDGS LTDsponsored ads$17,550,000
+65.6%
310,009
+129.6%
2.05%
+111.7%
AFAQ  AF ACQUISITION CORP$5,844,000
-0.2%
600,0000.0%0.68%
+27.7%
LCA  LANDCADIA HOLDINGS IV INC$4,870,000
-0.5%
500,0000.0%0.57%
+27.0%
BGSX  BUILD ACQUISITION CORP$4,361,000
+0.2%
450,0000.0%0.51%
+28.1%
PRPC  CC NEUBERGER PRINCIPAL HOLDN$3,908,000
-0.1%
400,0000.0%0.46%
+27.7%
CFIV  CF ACQUISITION CORP IV$1,586,000
+0.4%
163,0000.0%0.18%
+27.6%
AGCB  ALTIMETER GROWTH CORP 2$1,483,000
-3.5%
150,0000.0%0.17%
+22.7%
SPAQ  SPARTAN ACQUISITION CORP III$1,482,000
+1.0%
150,0000.0%0.17%
+29.1%
CFVI  CF ACQUISITION CORP VI$1,457,000
-0.3%
150,0000.0%0.17%
+26.9%
 RXR ACQUISITION CORP$972,000
+0.1%
100,0000.0%0.11%
+28.1%
CPTK  CROWN PROPTECH ACQUISITIONS$975,000
+0.8%
100,0000.0%0.11%
+29.5%
BIOT  BIOTECH ACQUISITION COMPANY$974,000
+0.7%
100,0000.0%0.11%
+29.5%
COLI  COLICITY INC$977,000
+0.2%
100,0000.0%0.11%
+28.1%
DHHC  DIAMONDHEAD HOLDINGS CORPcl a$972,000
+0.2%
100,0000.0%0.11%
+28.1%
SHAC  SCP & CO HEALTHCARE ACQUSTN$973,000
+0.5%
100,0000.0%0.11%
+28.1%
HIII  HUDSON EXECUTIVE INVES III$973,000
-0.2%
100,0000.0%0.11%
+28.1%
CFV  CF ACQUISITION CORP Vcl a$881,000
+0.3%
89,0000.0%0.10%
+28.8%
EQHA  EQ HEALTH ACQUISITION CORP$488,000
+1.0%
50,0000.0%0.06%
+29.5%
FACA  FIGURE ACQUISITION CORP I$492,000
-1.6%
50,0000.0%0.06%
+23.9%
AAC  ARES ACQUISITION CORPORATION$487,000
-0.2%
50,0000.0%0.06%
+26.7%
PAQC  PROVIDENT ACQUISITION CORPcl a$368,000
+0.5%
37,7310.0%0.04%
+30.3%
VTIQW  VECTOIQ ACQUISITION CORP II*w exp 01/07/202$301,000
-43.6%
389,9990.0%0.04%
-28.6%
LCAHW  LANDCADIA HOLDINGS IV INC*w exp 03/29/202$125,000
-5.3%
125,0000.0%0.02%
+25.0%
AFAQW  AF ACQUISITION CORP*w exp 03/23/202$112,000
-36.4%
200,0000.0%0.01%
-18.8%
BGSXWS SellBUILD ACQUISITION CORP*w exp 03/15/202$98,000
-27.4%
149,999
-0.0%
0.01%
-8.3%
DUNEW SellDUNE ACQUISITION CORP*w exp 10/29/202$98,000
-18.3%
149,999
-0.0%
0.01%0.0%
CFIVW SellCF ACQUISITION CORP IV*w exp 12/31/202$86,000
-21.1%
99,999
-0.0%
0.01%0.0%
PRPCWS  CC NEUBERGER PRINCIPAL HOLDN*w exp 99/99/999$80,000
-21.6%
80,0000.0%0.01%0.0%
VIIAW Sell7GC & CO HOLDINGS INC*w exp 12/23/202$54,000
-35.7%
92,499
-0.0%
0.01%
-25.0%
NXUWS SellNOVUS CAPITAL CORPORATION II*w exp 02/02/202$54,000
-8.5%
49,999
-0.0%
0.01%
+20.0%
PAQCW SellPROVIDENT ACQUISITION CORP*w exp 01/08/202$45,000
-23.7%
74,999
-0.0%
0.01%0.0%
SPAQWS SellSPARTAN ACQUISITION CORP III*w exp 02/04/202$41,000
-8.9%
37,499
-0.0%
0.01%
+25.0%
DLCAW  DEEP LAKE CAPITAL ACQUSTN CO*w exp 01/04/202$46,000
-16.4%
60,0000.0%0.01%0.0%
BIOTW  BIOTECH ACQUISITION COMPANY*w exp 11/30/202$33,000
-23.3%
50,0000.0%0.00%0.0%
CFVIW  CF ACQUISITION CORP VI*w exp 02/18/202$30,000
-16.7%
37,5000.0%0.00%
+33.3%
HCCCW  HEALTHCARE CAPITAL CORP*w exp 12/31/202$35,000
-2.8%
50,0000.0%0.00%
+33.3%
SHACW  SCP & CO HEALTHCARE ACQUSTN*w exp 01/27/202$29,000
-31.0%
50,0000.0%0.00%
-25.0%
IIIIW  INSU ACQUISITION CORP III*w exp 12/31/202$26,000
-33.3%
33,3330.0%0.00%
-25.0%
FCAXWS SellFORTRESS CAPITAL ACQUISITION*w exp 99/99/999$26,000
-18.8%
29,999
-0.0%
0.00%0.0%
FACAWS SellFIGURE ACQUISITION CORP I*w exp 03/31/202$27,000
-22.9%
24,999
-0.0%
0.00%0.0%
COLIW SellCOLICITY INC*w exp 02/24/202$17,000
-45.2%
19,999
-0.0%
0.00%
-33.3%
AACWS  ARES ACQUISITION CORPORATION*w exp 99/99/999$17,000
-32.0%
20,0000.0%0.00%0.0%
HIIIW SellHUDSON EXECUTIVE INVES III*w exp 02/22/202$17,000
-22.7%
19,999
-0.0%
0.00%0.0%
DHHCW SellDIAMONDHEAD HOLDINGS CORP*w exp 01/28/202$16,000
-40.7%
24,999
-0.0%
0.00%0.0%
EQHAWS SellEQ HEALTH ACQUISITION CORP*w exp 02/02/202$14,000
-22.2%
24,999
-0.0%
0.00%0.0%
RXRAW SellRXR ACQUISITION CORP*w exp 03/08/202$15,000
-28.6%
19,999
-0.0%
0.00%0.0%
CPTKWS  CROWN PROPTECH ACQUISITIONS*w exp 99/99/999$18,000
-35.7%
33,3330.0%0.00%
-33.3%
NSTBWS ExitNORTHERN STAR INVSTMNT CORP*w exp 01/31/202$0-10,000
-100.0%
-0.00%
HCICW ExitHENNESSY CAPITAL INVS CORP V*w exp 01/20/202$0-12,233
-100.0%
-0.00%
CFFVW ExitCF ACQUISITION CORP V*w exp 01/25/202$0-40,000
-100.0%
-0.00%
SRNGW ExitSOARING EAGLE ACQUISITION CO*w exp 02/23/202$0-40,000
-100.0%
-0.01%
NXU ExitNOVUS CAPITAL CORPORATION II$0-150,000
-100.0%
-0.13%
SRNG ExitSOARING EAGLE ACQUISITION CO$0-200,000
-100.0%
-0.18%
EIX ExitEDISON INTL$0-143,471
-100.0%
-0.76%
ROOT ExitROOT INC$0-1,249,564
-100.0%
-1.24%
PCG ExitPG&E CORP$0-6,649,428
-100.0%
-6.18%
About Centerbridge Partners

Centerbridge Partners is a private investment management firm that was founded in 2005 by Mark Gallogly and Jeffrey Aronson. The firm is headquartered in New York City and has additional offices in London and Hong Kong. Centerbridge Partners manages over $25 billion in assets across a range of investment strategies, including private equity, distressed debt, and real estate.

The firm has a strong leadership team, with Mark Gallogly serving as the CEO and Jeffrey Aronson as the Chairman and Chief Investment Officer. The COO is William Rahm, who oversees the firm's operations and infrastructure.

Centerbridge Partners has a reputation for being a highly disciplined and opportunistic investor, with a focus on identifying undervalued assets and unlocking value through operational improvements. The firm has a track record of successfully investing in a range of industries, including healthcare, energy, and financial services.

One notable investment made by Centerbridge Partners was its acquisition of Syncora Holdings, a financial guarantee insurance company, in 2013. The firm was able to turn around the struggling company by implementing operational improvements and strategic initiatives, ultimately leading to a successful exit.

Overall, Centerbridge Partners is a well-respected investment management firm with a strong leadership team and a proven track record of success.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GENCO SHIPPING & TRADING LTD26Q4 202218.0%
AMERICAN RENAL ASSOCS HLDGS19Q4 202034.8%
EXTENDED STAY AMER INC18Q4 202064.1%
AMBAC FINL GROUP INC17Q1 20184.8%
QUAD / GRAPHICS INC16Q4 20176.1%
IRSA INVERSIONES Y REP S A16Q3 20191.4%
ALLY FINL INC15Q4 201712.4%
WMIH CORP13Q3 20182.5%
CRESUD S A C I F Y A13Q4 20160.8%
ATLANTICA YIELD PLC12Q1 20199.0%

View Centerbridge Partners's complete holdings history.

Latest significant ownerships (13-D/G)
Centerbridge Partners Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
KV PHARMACEUTICAL CO /DE/March 03, 2011? ?

View Centerbridge Partners's complete significant-ownership history.

Latest filings
TypeFiled
40-APP/A2024-03-04
13F-HR2024-02-14
13F-HR2023-11-14
40-APP2023-10-16
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16

View Centerbridge Partners's complete filings history.

Compare quarters

Export Centerbridge Partners's holdings